Gudiol González, CarlotaHicklen, Rachel S.Okhyusen, Pablo C.Malek, Alexandre E.Kontoyiannis, Dimitrios P.2023-04-252023-04-252022-10-272328-8957https://hdl.handle.net/2445/197190Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of infections as simulators of irAEs in cancer patients.5 p.application/pdfengcc-by-nc-nd (c) Gudiol González, Carlota et al., 2022https://creativecommons.org/licenses/by-nc-nd/4.0/OncologiaToxicitat dels medicamentsInfeccionsOncologyDrug toxicityInfectionsinfo:eu-repo/semantics/article7304912023-04-25info:eu-repo/semantics/openAccess36420059